Loading memory…
Loading memory…
Patent portfolio assigned to GraphWear Technologies (verified via public assignee records). Estimated patent count: 3. Needle-free nanotech (graphene FET) continuous glucose monitor; data labels industry as fintech but it is medtech. Patents assigned to Graphwear Technologies Inc (polar-fluid gated FET devices, replaceable sensor systems). No named customers (pre/early commercial).